Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vaccine Effectiveness × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1044 Neoplasms 782 Carcinoma, Non-Small-Cell Lung 778 Prostatic Neoplasms 602 Lung Neoplasms 494 Colorectal Neoplasms 491 Neoplasm Metastasis 406 Leukemia, Myeloid, Acute 366 Multiple Myeloma 361 Ovarian Neoplasms 340 Melanoma 293 Squamous Cell Carcinoma of Head and Neck 286 Recurrence 277 Pancreatic Neoplasms 274 Brain Neoplasms 243 Carcinoma, Hepatocellular 238 Glioblastoma 228 Triple Negative Breast Neoplasms 218 Stomach Neoplasms 214 Head and Neck Neoplasms 199 Endometrial Neoplasms 194 Lymphoma 192 Uterine Cervical Neoplasms 190 Precursor Cell Lymphoblastic Leukemia-Lymphoma 189 Carcinoma, Renal Cell 189 Sarcoma 176 Glioma 176 Lymphoma, Non-Hodgkin 175 Lymphoma, Large B-Cell, Diffuse 174 Urinary Bladder Neoplasms 172

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡